Evogene (TSE:EVGN) PT Lowered to C$8.00

Evogene (TSE:EVGNGet Rating) had its target price lowered by Pi Financial from C$8.25 to C$8.00 in a research report report published on Wednesday, BayStreet.CA reports.

Evogene Stock Performance

Evogene Company Profile

(Get Rating)

Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and guide the development of life-science products based on microbes, small molecules and genetic elements.

Featured Articles

Receive News & Ratings for Evogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene and related companies with MarketBeat.com's FREE daily email newsletter.